Jiangsu Hengrui Pharmaceuticals (01276) spent 19.9599 million yuan on January 30 to repurchase 343,100 A-shares.
Hengrui Medicine (01276) announced that on January 30, 2026, the company spent 1995.99 million yuan to repurchase 343,100 shares of A-shares at a repurchase price of 58.12-58.21 yuan per share.
Jiangsu Hengrui Pharmaceuticals (01276) announced that on January 30, 2026, the company will spend RMB 1995.99 million to repurchase 343,100 A shares at a repurchase price of RMB 58.12-58.21 per share.
Related Articles
Guosen: RWA welcomes the era of strict supervision.
Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!
Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.
Guosen: RWA welcomes the era of strict supervision.
Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!
Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
